Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103915986 | 10391598 | 6 | F | 2006 | 20160805 | 20140818 | 20160810 | EXP | US-009507513-1408USA005681 | MERCK | 0.00 | F | Y | 100.32000 | KG | 20160810 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103915986 | 10391598 | 1 | PS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 10 MG, UNKNOWN | 20560 | 10 | MG | TABLET | |||||||
| 103915986 | 10391598 | 2 | SS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | 20560 | 70 | MG | TABLET | /wk | ||||||
| 103915986 | 10391598 | 3 | SS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 35 MG, UNKNOWN | 20560 | 35 | MG | TABLET | |||||||
| 103915986 | 10391598 | 4 | SS | FOSAMAX PLUS D | ALENDRONATE SODIUMCHOLECALCIFEROL | 1 | Oral | 70 MG, QW | 0 | 70 | MG | TABLET | /wk | ||||||
| 103915986 | 10391598 | 5 | SS | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | U | U | 0 | 70 | MG | /wk | |||||
| 103915986 | 10391598 | 6 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103915986 | 10391598 | 1 | Osteoporosis postmenopausal |
| 103915986 | 10391598 | 4 | Osteoporosis postmenopausal |
| 103915986 | 10391598 | 5 | Osteoporosis postmenopausal |
| 103915986 | 10391598 | 6 | Hypothyroidism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103915986 | 10391598 | DS |
| 103915986 | 10391598 | HO |
| 103915986 | 10391598 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103915986 | 10391598 | Ankle fracture | |
| 103915986 | 10391598 | Back disorder | |
| 103915986 | 10391598 | Depression | |
| 103915986 | 10391598 | Foot fracture | |
| 103915986 | 10391598 | Haemorrhagic anaemia | |
| 103915986 | 10391598 | Hand fracture | |
| 103915986 | 10391598 | Head injury | |
| 103915986 | 10391598 | Hip fracture | |
| 103915986 | 10391598 | Hypertension | |
| 103915986 | 10391598 | Intervertebral disc degeneration | |
| 103915986 | 10391598 | Scoliosis | |
| 103915986 | 10391598 | Type 2 diabetes mellitus | |
| 103915986 | 10391598 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103915986 | 10391598 | 1 | 20000425 | 20011117 | 0 | |
| 103915986 | 10391598 | 2 | 200102 | 200602 | 0 | |
| 103915986 | 10391598 | 3 | 20040330 | 20050124 | 0 | |
| 103915986 | 10391598 | 4 | 20060628 | 200911 | 0 | |
| 103915986 | 10391598 | 5 | 20091124 | 201107 | 0 | |
| 103915986 | 10391598 | 6 | 1999 | 0 |